Report
EUR 900.30 For Business Accounts Only

Smoking Tobacco in Australia, 2016

Summary

The Australian market for tobacco products is in long-term decline due to strong anti-tobacco laws, high taxes, and low smoking rates among consumers. However, as of 2015, smoking tobacco accounted for 10.9% of all tobacco consumption, up from 6.5% in 2005, indicating a consumer shift away from manufactured cigarettes to slightly cheaper alternatives, such as smoking tobacco. Nevertheless, the highly regulated nature of the Australian tobacco market will limit the abilities of smoking tobacco brands to capitlize on their growing popularity in the longer term. This category is dominated by two major tobacco companies, BAT and Imperial Tobacco, which utilize local production and imports to maintain the smoking tobacco market in the country.

Key Findings

- Smoking tobacco accounted for 10.9% of the tobacco market in 2015.
- Smoking tobacco consumption is forecast to grow to 2,050 tons in 2016 compared to 1,597 tons in 2004.
- Imperial Tobacco dominates the market with a 61.5% volume share, as of 2015.
- Per capita smoking tobacco consumption is forecast to decline from 88.4g a year in 2015 to 73.4g in 2025.

Synopsis

Smoking Tobacco in Australia is an analytical report that provides extensive and highly detailed current and future market trends in the Australian tobacco market. It covers market size and structure along with per capita and overall consumption. Additionally, it focuses on brand data, retail pricing, prospects, and forecasts for sales and consumption until 2025.

Reasons To Buy

Get a detailed understanding of consumption to align your sales and marketing efforts with the latest trends in the market. Identify the areas of growth and opportunities, which will aid effective marketing planning. The differing growth rates in regional product sales drive fundamental shifts in the market. This report provides detailed, authoritative data on these changes - prime intelligence for marketers. Understand the market dynamics and essential data to benchmark your position and to identify where to compete in the future.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch